Success takes the right partner and strong systems.
ATN's Franchise Lens shares the keys to preparing for franchise success.
New research shows that popular wearables could be misleading consumers — especially those with higher body fat percentages — about how many calories they're actually burning during workouts, a potential issue for the "track-everything" movement
New research shows GLP-1 users are shelling out roughly $449 a month on fitness amid broader lifestyle shifts, although the general consensus is conflicted on whether weight-loss drugs are a net benefit for the fitness and wellness industry
In a new study, waist circumference proved a better predictor of mortality than BMI among older adults, supporting a broader shift in fitness from tracking scale weight to measuring fat, muscle and metabolic health
The focus of the partnership has shifted to whether solutions targeting the microbiome can deliver benefits alongside GLP-1-based medicines
A peer-reviewed study analyzing nearly 475,000 nights of sleep found that Apollo Neuro wearable users gained an average of 46 extra minutes of sleep per night, and slept better and deper thanks to the wearable's AI-powered vibration tech
A 30-year study indicates that weekly strength training for 90 to 120 minutes has serious benefits for lowering risk of death, with no further benefit found above that duration
Fitbit data from 750 adults found that daily movement and exercise levels declined after people started taking GLP-1 weight-loss drugs.
The study reveals numerous benefits of an integrated care model that combines weight-loss drugs with exercise, especially strength training.
Early clinical trial results show that apitegromab dramatically reduced lean mass loss in people taking tirzepatide, the main ingredient in Mounjaro.
Rock Health's 2025 survey finds 57% of Americans own a wearable or connected device, but growth has plateaued. Here's what comes next.
Sign Up to Our Newsletter
